Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M S Maurer"'
Autor:
S Bruce, M Cuomo, H Yarmohammadi, E Y Wan, D Saluja, R Sciacca, H Garan, J M Griffin, M S Maurer, A B Biviano
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background/Introduction Transthyretin cardiac amyloidosis (ATTR-CA) is associated with an increased incidence of arrhythmias. We hypothesized that non-invasive, two-week outpatient cardiac rhyth
Autor:
M Fontana, K Buchholtz, M D M Engelmann, M Grogan, G K Hovingh, A V Kristen, P Poulsen, S J Shah, M S Maurer
Publikováno v:
European Heart Journal. 43
Introduction Transthyretin amyloid cardiomyopathy (ATTR-CM) is a chronic condition associated with progressive heart failure, resulting from extracellular deposition of misfolded transthyretin (TTR) protein as amyloid fibrils in the myocardium. Curre
Autor:
N Harano, L W Liang, K Hasegawa, M S Maurer, A Tower-Rader, M A Fifer, M P Reilly, Y J Shimada
Publikováno v:
European Heart Journal. 43
Background Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiac disorders and affects 1 in 200–500 individuals. HCM is known to be heterogeneous. Approximately 20–30% of patients with HCM develop atrial fibrillation (AF), w
Publikováno v:
European Heart Journal. 43
Background Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy affecting 1 in 200–500 people in the US. It is characterized by a diverse clinical course, and only a subset of patients with HCM experience major adverse cardio
Publikováno v:
European Heart Journal. 42
Background Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease, and a subset (10–15%) of patients per year experience major adverse cardiovascular events (MACE). Current risk prediction models based solely on clinical data have yielded lim
Publikováno v:
European Heart Journal. 42
Introduction Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) represents myocardial fibrosis. In patients with hypertrophic cardiomyopathy (HCM), LGE on CMR has been associated with an increased risk of sudden cardiac dea
Publikováno v:
European Heart Journal. 42
Background Hypertrophic cardiomyopathy (HCM) is caused by mutations in the genes coding for proteins essential in normal myocardial contraction. However, it remains unclear through which molecular pathways gene mutations mediate the development and p
Publikováno v:
Minerva cardioangiologica. 59(4)
Pressure volume (PV) based analysis, using classic hemodynamic principles, has served as a basis for our understanding of cardiac physiology and disease states for decades. However, PV analysis has been restricted to primarily the basic research sett
Publikováno v:
MD Conference Express. 6:33-34
Autor:
M. S. Maurer
Publikováno v:
Journal of Fluids Engineering. 61:654-656